Searched for
GLAXOSMITHKLINE ASIA PVT LTD
These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 25%Here’s a thing investors in equity need to keep in mind. A large part of the upmove one might see in the next one or two trading sessions w...- These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsHere’s one thing to remember in the market: When there is a strong correction that is led by a change in the fundamentals of a sector, it i...
- Wealth creation has another name: Ignore noise & Trump. Just hold on to good businesses; 22 stocks from different sectors that fit the billWith the additional 25% tariff all but a reality, here's a question: What will President Trump say or do next? Can anyone predict that? The...
- Think bullish, but learn to live with & ignore volatility: 5 stocks from different sectors with an upside potential of up to 42%The probability of a correction if there is no positive development on the India-US trade deal is quite high. The fact, however, remains th...
- Will PLI help Indian pharma gain market share at cost of MNCs?Indian pharmaceutical companies are becoming more aggressive and increasing their market share and capex. Companies such as Divis, Dr Reddy...
- GSK Pharma sheds 2% as Q3 profit drops, expenses riseTotal income in October-December 2021 stood at Rs 826.24 crore as compared with Rs 805.89 crore in the year-ago period, PTI reported.
- GSK, Generali Deals ClearedThe Competition Commission of India (CCI) on Monday approved the proposed acquisition of consumer healthcare company GlaxoSmithKline Asia P...
- Oberoi Realty acquires 4.2-acre land parcel in Mumbai’s Bhandup suburbRealty developer Oberoi Realty has acquired an over 4.2-acre land parcel on LBS Marg in Mumbai’s central suburb Bhandup for Rs 115 crore. T...
- Godrej Consumer jumps most in Asia as it hires CEO from Unilever“Godrej has underperformed most of its peers in the past few years, which may change as the new leader brings in a new strategy that may en...
- Government brings India’s economy into focus amid privatization pushIndia has jumped 14 places to 63rd in the World Bank’s annual rankings for ease of doing business, rolled back a levy on foreign funds, inj...
- Bharat Biotech's subsidiary Chiron Behring launches anti-rabies vaccine“In our ongoing commitment to address the supply shortages of rabies vaccine, we are making additional investments to increase production c...
- Once-in-a-lifetime deals fuel a $100 billion India M&A boomA combination of various factors has created an unprecedented opportunity for dealmaking in India.
- India's logged a record $98 billion in deals this yearTechnology, media and telecom along with financial services will probably remain the most active sectors for inbound deal-making this year ...
- At the epicenter of a war, Indian antibiotic startups are fighting back“We’re creating a bullet against organisms that are taking out humanity. Wouldn’t it be nice to get a battleground to test it on that’s rea...
- How shall we adjudicate if parliamentary panel report is disputed: Supreme Court"We appreciate the separation of powers. The question is as to how we will deal with the parliamentary committee report, once a party conte...
- Can't stay away from issue just because Parliament is debating it: Supreme CourtIt said that the apex court can enforce its orders under Article 142 and ask for setting up of commissions, seek reports and order enquiry ...
- Glaxo decides to cut price of Crocin by 50 per centGlaxo had stopped manufacturing Crocin from September 2012, and had launched the variant 'Crocin Advance' at a higher price.
Load More
